| 38.98 Delayed Data As of 4:01pm ET |  -0.40 / -1.02%Today’s Change | 34.37 Today|||52-Week Range 46.47 | -10.70% Year-to-Date |
| Previous close | 39.38 |
| Today’s open | 39.03 |
| Day’s range | 38.81 - 39.50 |
| Volume | 29,429,714 |
| Average volume (3 months) | 25,329,863 |
| Market cap | $218.6B |
| Earnings growth (last year) | -46.78% |
| Earnings growth (this year) | -3.93% |
| Earnings growth (next 5 years) | +5.40% |
| Revenue growth (last year) | +2.10% |
| P/E ratio | 21.0 |
| Price/Sales | 4.86 |
| Price/Book | 3.55 |
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +0.27 | +0.37% |
| NVSNovartis | -1.01 | -1.32% |
| ABTAbbott Laboratories | +0.59 | +0.80% |
| LLYEli Lilly and Co | +0.27 | +0.23% |
| Next reporting date | April 30, 2019 |
| EPS forecast (this quarter) | $0.75 |
| Annual revenue (last year) | $53.6B |
| Annual profit (last year) | $11.2B |
| Net profit margin | 20.77% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Director, Chief Executive & Operating Officer Albert Bourla |
Chief Financial Officer & EVP-Business Operations Frank A. D'Amelio |
Corporate headquarters New York, New York |
